2608004971
  • Open Access
  • Review

19F NMR as a Powerful Tool for Revealing Disease- and Metabolism-Related Membrane Protein Dynamics

  • Zheng Zhou,   
  • Wenge Dong * and 
  • Chan Cao *

Received: 01 June 2026 | Revised: 08 July 2026 | Accepted: 19 August 2026 | Published: 17 November 2026

Abstract

Membrane proteins are central mediators of cellular material transport, signal transduction, and intercellular communication. Their dysfunction is closely linked to a variety of major diseases. Although traditional structural biology techniques can achieve high-resolution global analysis of membrane proteins, the lack of understanding of their dynamic structural mechanisms severely hinders the in-depth comprehension of their physiological functions and the development of targeted therapeutic drugs. 19F nuclear magnetic resonance (19F NMR) spectroscopy, with its unique advantages including high sensitivity and minimal endogenous background interference, provides a powerful means of analyzing the conformational changes and interactions of membrane proteins. This review begins by comparing the main methods currently used in the study of membrane protein structure and function, clarifying the scope of application and the limitations of each technique. It then focuses on the unique advantages of 19F NMR in characterizing the local structure of membrane proteins, analyzing their dynamics, and investigating protein–protein and protein–ligand interactions. Building on this, we summarize various 19F labeling strategies and their applicable scenarios, and review cutting-edge applications of this technique in the study of disease- and metabolism-related membrane proteins, covering structural elucidation of key membrane proteins such as G protein-coupled receptors (GPCRs) and ion channels, as well as real-time monitoring of functionally related conformational changes. Finally, using proteins associated with sleep disorders, cancer, and metabolic diseases as examples, we review significant advances in the application of 19F NMR in targeted drug screening and the development of allosteric modulators, highlighting the unique value of this technique in filling gaps in dynamic structural information, advancing the elucidation of metabolic disease mechanisms, and facilitating precision drug discovery.

Graphical Abstract

References 

  • 1.

    Overington, J.P.; Al-Lazikani, B.; Hopkins, A.L. How Many Drug Targets Are There? Nat. Rev. Drug Discov. 2006, 5, 993–996. https://doi.org/10.1038/nrd2199.

  • 2.

    Chen, R.; Zou, J.; Chen, J.; et al. Pattern Recognition Receptors: Function, Regulation and Therapeutic Potential. Signal Transduct. Target. Ther. 2025, 10, 216. https://doi.org/10.1038/s41392-025-02264-1.

  • 3.

    Pishesha, N.; Harmand, T.J.; Ploegh, H.L. A Guide to Antigen Processing and Presentation. Nat Rev Immunol 2022, 22, 751–764. https://doi.org/10.1038/s41577-022-00707-2.

  • 4.

    Chen, L.; Flies, D.B. Molecular Mechanisms of T Cell Co-Stimulation and Co-Inhibition. Nat. Rev. Immunol. 2013, 13, 227–242. https://doi.org/10.1038/nri3405.

  • 5.

    He, X.; Xu, C. Immune Checkpoint Signaling and Cancer Immunotherapy. Cell Res. 2020, 30, 660–669. https://doi.org/10.1038/s41422-020-0343-4.

  • 6.

    Rees, D.C.; Johnson, E.; Lewinson, O. ABC Transporters: The Power to Change. Nat. Rev. Mol. Cell Biol. 2009, 10, 218–227. https://doi.org/10.1038/nrm2646.

  • 7.

    Bakheet, T.M.; Doig, A.J. Properties and Identification of Human Protein Drug Targets. Bioinformatics 2009, 25, 451–457. https://doi.org/10.1093/bioinformatics/btp002.

  • 8.

    Atash, K.; Boesjes, C.M.; de Bruin-Weller, M.S. Targeting OX40: Rocatinlimab—A Novel Therapy for Atopic Dermatitis. Lancet 2026, 407, 4–5. https://doi.org/10.1016/s0140-6736(25)02152-x.

  • 9.

    Hodi, F.S.; O’Day, S.J.; McDermott, D.F.; et al. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. N. Engl. J. Med. 2010, 363, 711–723. https://doi.org/10.1056/nejmoa1003466.

  • 10.

    Tang, Z.; Veillette, A. Inhibitory Immune Checkpoints in Cancer Immunotherapy. Sci. Immunol. 2025, 10, eadv6870. https://doi.org/10.1126/sciimmunol.adv6870.

  • 11.

    Bucciarelli, L.; Cimino, V.; Dell’Osso, B.; et al. Psychotropic Effects of GLP-1R Agonists. Pharmacol. Res. 2025, 222, 108036. https://doi.org/10.1016/j.phrs.2025.108036.

  • 12.

    De Block, C.E.M.; Dirinck, E.; Verhaegen, A.; et al. Efficacy and Safety of High-Dose Glucagon-like Peptide-1, Glucagon-like Peptide-1/Glucose-Dependent Insulinotropic Peptide, and Glucagon-like Peptide-1/Glucagon Receptor Agonists in Type 2 Diabetes. Diabetes Obes. Metab. 2022, 24, 788–805. https://doi.org/10.1111/dom.14640.

  • 13.

    Chipot, C.; Dehez, F.O.; Schnell, J.R.; et al. Perturbations of Native Membrane Protein Structure in Alkyl Phosphocholine Detergents: A Critical Assessment of NMR and Biophysical Studies. Chem. Rev. 2018, 118, 3559–3607. https://doi.org/10.1021/acs.chemrev.7b00570.

  • 14.

    Zhou, H.X.; Cross, T.A. Influences of Membrane Mimetic Environments on Membrane Protein Structures. Annu. Rev. Biophys. 2013, 42, 361–392. https://doi.org/10.1146/annurev-biophys-083012-130326.

  • 15.

    Sekhar, A.; Kay, L.E. An NMR View of Protein Dynamics in Health and Disease. Annu. Rev. Biophys. 2019, 48, 297–319. https://doi.org/10.1146/annurev-biophys-052118-115647.

  • 16.

    Vercellino, I.; Sazanov, L.A. The Assembly, Regulation and Function of the Mitochondrial Respiratory Chain. Nat. Rev. Mol. Cell Biol. 2022, 23, 141–161. https://doi.org/10.1038/s41580-021-00415-0.

  • 17.

    Kato, H.E.; Zhang, F.; Yizhar, O.; et al. Crystal Structure of the Channelrhodopsin Light-Gated Cation Channel. Nature 2012, 482, 369–374. https://doi.org/10.1038/nature10870.

  • 18.

    Kermani, A.A. A Guide to Membrane Protein X-ray Crystallography. FEBS J. 2021, 288, 5788–5804. https://doi.org/10.1111/febs.15676.

  • 19.

    Bill, R.M.; Henderson, P.J.F.; Iwata, S.; et al. Overcoming Barriers to Membrane Protein Structure Determination. Nat. Biotechnol. 2011, 29, 335–340. https://doi.org/10.1038/nbt.1833.

  • 20.

    Wu, K.; Wu, D.; Zhu, L.; et al. Application of Monolayer Graphene and Its Derivative in Cryo-EM Sample Preparation. Int. J. Mol. Sci. 2021, 22, 8940. https://doi.org/10.3390/ijms22168940.

  • 21.

    Yip, K.M.; Fischer, N.; Paknia, E.; et al. Atomic-Resolution Protein Structure Determination by Cryo-EM. Nature 2020, 587, 157–161. https://doi.org/10.1038/s41586-020-2833-4.

  • 22.

    Wentinck, K.; Gogou, C.; Meijer, D.H. Putting on Molecular Weight: Enabling Cryo-EM Structure Determination of Sub-100-kDa Proteins. Curr. Res. Struct. Biol. 2022, 4, 332–337. https://doi.org/10.1016/j.crstbi.2022.09.005.

  • 23.

    Zhong, E.D.; Bepler, T.; Berger, B.; et al. CryoDRGN: Reconstruction of Heterogeneous Cryo-EM Structures Using Neural Networks. Nat. Methods 2021, 18, 176–185. https://doi.org/10.1038/s41592-020-01049-4.

  • 24.

    Danmaliki, G.I.; Hwang, P.M. Solution NMR Spectroscopy of Membrane Proteins. Biochim. et Biophys. Acta BBA-Biomembr. 2020, 1862, 183356. https://doi.org/10.1016/j.bbamem.2020.183356.

  • 25.

    Wider, G.; Wüthrich, K. NMR Spectroscopy of Large Molecules and Multimolecular Assemblies in Solution. Curr. Opin. Struct. Biol. 1999, 9, 594–601. https://doi.org/10.1016/s0959-440x(99)00011-1.

  • 26.

    Marley, J.; Lu, M.; Bracken, C. A Method for Efficient Isotopic Labeling of Recombinant Proteins. J. Biomol. NMR 2001, 20, 71–75. https://doi.org/10.1023/a:1011254402785.

  • 27.

    Marty, M.T.; Zhang, H.; Cui, W.; et al. Native Mass Spectrometry Characterization of Intact Nanodisc Lipoprotein Complexes. Anal. Chem. 2012, 84, 8957–8960. https://doi.org/10.1021/ac302663f.

  • 28.

    Suzuki, M.; Sakurai, K.; Lee, Y.H.; et al. A Back Hydrogen Exchange Procedure via the Acid-Unfolded State for a Large Protein. Biochemistry 2012, 51, 5564–5570. https://doi.org/10.1021/bi300495p.

  • 29.

    Fernandez, C. TROSY in NMR Studies of the Structure and Function of Large Biological Macromolecules. Curr. Opin. Struct. Biol. 2003, 13, 570–580. https://doi.org/10.1016/j.sbi.2003.09.009.

  • 30.

    Yu, H. Extending the Size Limit of Protein Nuclear Magnetic Resonance. Proc. Natl. Acad. Sci. USA 1999, 96, 332–334. https://doi.org/10.1073/pnas.96.2.332.

  • 31.

    Raschle, T.; Hiller, S.; Yu, T.Y.; et al. Structural and Functional Characterization of the Integral Membrane Protein VDAC-1 in Lipid Bilayer Nanodiscs. J. Am. Chem. Soc. 2009, 131, 17777–17779. https://doi.org/10.1021/ja907918r.

  • 32.

    O’Brien, E.S.; Lin, D.W.; Fuglestad, B.; et al. Improving Yields of Deuterated, Methyl Labeled Protein by Growing in H2O. J. Biomol. NMR 2018, 71, 263–273. https://doi.org/10.1007/s10858-018-0200-7.

  • 33.

    Miyanoiri, Y.; Takeda, M.; Terauchi, T.; et al. Recent Developments in Isotope-Aided NMR Methods for Supramolecular Protein Complexes –SAIL Aromatic TROSY. Biochim. et Biophys. Acta BBA-Gen. Subj. 2020, 1864, 129439. https://doi.org/10.1016/j.bbagen.2019.129439.

  • 34.

    Gronenborn, A.M. Small, but Powerful and Attractive: 19F in Biomolecular NMR. Structure 2022, 30, 6–14. https://doi.org/10.1016/j.str.2021.09.009.

  • 35.

    Werle, Y.; Kovermann, M. Fluorine Labeling and 19F NMR Spectroscopy to Study Biological Molecules and Molecular Complexes. Chem.–A Eur. J. 2025, 31, e202402820. https://doi.org/10.1002/chem.202402820.

  • 36.

    Stadmiller, S.S.; Aguilar, J.S.; Waudby, C.A.; et al. Rapid Quantification of Protein-Ligand Binding via 19F NMR Lineshape Analysis. Biophys. J. 2020, 118, 2537–2548. https://doi.org/10.1016/j.bpj.2020.03.031.

  • 37.

    Prosser, R.S.; Alonzi, N.A. Discerning Conformational Dynamics and Binding Kinetics of GPCRs by 19F NMR. Curr. Opin. Pharmacol. 2023, 72, 102377. https://doi.org/10.1016/j.coph.2023.102377.

  • 38.

    Huang, S.K.; Pandey, A.; Tran, D.P.; et al. Delineating the Conformational Landscape of the Adenosine A2A Receptor during G Protein Coupling. Cell 2021, 184, 1884–1894.e14. https://doi.org/10.1016/j.cell.2021.02.041.

  • 39.

    Frere, G.A.; Hasabnis, A.; Francisco, C.B.; et al. Next-Generation Tags for Fluorine Nuclear Magnetic Resonance: Designing Amplification of Chemical Shift Sensitivity. J. Am. Chem. Soc. 2024, 146, 3052–3064. https://doi.org/10.1021/jacs.3c09730.

  • 40.

    Sušac, L.; O’Connor, C.; Stevens, R.C.; et al. In-Membrane Chemical Modification (IMCM) for Site-Specific Chromophore Labeling of GPCRs. Angew. Chem. 2015, 127, 15461–15464. https://doi.org/10.1002/ange.201508506.

  • 41.

    Thakur, N.; Ray, A.P.; Sharp, L.; et al. Anionic Phospholipids Control Mechanisms of GPCR-G Protein Recognition. Nat. Commun. 2023, 14, 794. https://doi.org/10.1038/s41467-023-36425-z.

  • 42.

    Larda, S.T.; Pichugin, D.; Prosser, R.S. Site-Specific Labeling of Protein Lysine Residues and N-Terminal Amino Groups with Indoles and Indole-Derivatives. Bioconjugate Chem. 2015, 26, 2376–2383. https://doi.org/10.1021/acs.bioconjchem.5b00457.

  • 43.

    Edwards, J.M.; Derrick, J.P.; van der Walle, C.F.; et al. 19F NMR as a Tool for Monitoring Individual Differentially Labeled Proteins in Complex Mixtures. Mol. Pharm. 2018, 15, 2785–2796. https://doi.org/10.1021/acs.molpharmaceut.8b00282.

  • 44.

    Iwasaki, T.; Miyajima-Nakano, Y.; Fukazawa, R.; et al. Escherichia Coli Amino Acid Auxotrophic Expression Host Strains for Investigating Protein Structure–Function Relationships. J. Biochem. 2021, 169, 387–394. https://doi.org/10.1093/jb/mvaa140.

  • 45.

    Kim, H.W.; Perez, J.A.; Ferguson, S.J.; et al. The Specific Incorporation of Labelled Aromatic Amino Acids into Proteins through Growth of Bacteria in the Presence of Glyphosate. FEBS Lett. 1990, 272, 34–36. https://doi.org/10.1016/0014-5793(90)80442-l.

  • 46.

    Mukhopadhyay, A.; Li, Y.; Cliff, M. J.; et al. Enzyme Stabilisation Due to Incorporation of a Fluorinated Non-Natural Amino Acid at the Protein Surface. Sci. Rep. 2024, 14, 28080. https://doi.org/10.1038/s41598-024-79711-6.

  • 47.

    Sixl, F.; King, R. W.; Bracken, M.; et al. ¹⁹F-n.m.r. Studies of Ligand Binding to 5-Fluorotryptophan- and 3-Fluorotyrosine-Containing Cyclic AMP Receptor Protein from Escherichia coli. Biochem. J. 1990, 266, 545–552. https://doi.org/10.1042/bj2660545.

  • 48.

    Lian, C.; Le, H.; Montez, B.; et al. Fluorine-19 Nuclear Magnetic Resonance Spectroscopic Study of Fluorophenylalanine- and Fluorotryptophan-Labeled Avian Egg White Lysozymes. Biochemistry 1994, 33, 5498–5509. https://doi.org/10.1021/bi00183a029.

  • 49.

    Larda, S.T.; Simonetti, K.; Al-Abdul-Wahid, M.S.; et al. Dynamic Equilibria between Monomeric and Oligomeric Misfolded States of the Mammalian Prion Protein Measured by19 F NMR. J. Am. Chem. Soc. 2013, 135, 10533–10541. https://doi.org/10.1021/ja404584s.

  • 50.

    Arntson, K.E.; Pomerantz, W.C.K. Protein-Observed Fluorine NMR: A Bioorthogonal Approach for Small Molecule Discovery. J. Med. Chem. 2016, 59, 5158–5171. https://doi.org/10.1021/acs.jmedchem.5b01447.

  • 51.

    Jones, D.H.; Cellitti, S.E.; Hao, X.; et al. Site-Specific Labeling of Proteins with NMR-Active Unnatural Amino Acids. J. Biomol. NMR 2010, 46, 89–100. https://doi.org/10.1007/s10858-009-9365-4.

  • 52.

    Cellitti, S.E.; Jones, D.H.; Lagpacan, L.; et al. In Vivo Incorporation of Unnatural Amino Acids to Probe Structure, Dynamics, and Ligand Binding in a Large Protein by Nuclear Magnetic Resonance Spectroscopy. J. Am. Chem. Soc. 2008, 130, 9268–9281. https://doi.org/10.1021/ja801602q.

  • 53.

    Wang, X.; Liu, D.; Shen, L.; et al. A Genetically Encoded F-19 NMR Probe Reveals the Allosteric Modulation Mechanism of Cannabinoid Receptor 1. J. Am. Chem. Soc. 2021, 143, 16320–16325. https://doi.org/10.1021/jacs.1c06847.

  • 54.

    Qianzhu, H.; Welegedara, A.P.; Williamson, H.; et al. Genetic Encoding of Para-Pentafluorosulfanyl Phenylalanine: A Highly Hydrophobic and Strongly Electronegative Group for Stable Protein Interactions. J. Am. Chem. Soc. 2020, 142, 17277–17281. https://doi.org/10.1021/jacs.0c07976.

  • 55.

    Gerig, J.T. Fluorine NMR of Proteins. Prog. Nucl. Magn. Reson. Spectrosc. 1994, 26, 293–370. https://doi.org/10.1016/0079-6565(94)80009-x.

  • 56.

    Boeszoermenyi, A.; Chhabra, S.; Dubey, A.; et al. Aromatic 19F-13C TROSY: A Background-Free Approach to Probe Biomolecular Structure, Function, and Dynamics. Nat. Methods 2019, 16, 333–340. https://doi.org/10.1038/s41592-019-0334-x.

  • 57.

    Frei, J.N.; Broadhurst, R.W.; Bostock, M.J.; et al. Conformational Plasticity of Ligand-Bound and Ternary GPCR Complexes Studied by 19F NMR of the β1-Adrenergic Receptor. Nat. Commun. 2020, 11, 669. https://doi.org/10.1038/s41467-020-14526-3.

  • 58.

    Manglik, A.; Kim, T.H.; Masureel, M.; et al. Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling. Cell 2015, 161, 1101–1111. https://doi.org/10.1016/j.cell.2015.04.043.

  • 59.

    Sun, X.; Jaeger, M.; Kelly, J.W.; et al. Mispacking of the Phe87 Side Chain Reduces the Kinetic Stability of Human Transthyretin. Biochemistry 2018, 57, 6919–6922. https://doi.org/10.1021/acs.biochem.8b01046.

  • 60.

    Sun, X.; Dyson, H.J.; Wright, P.E. Kinetic Analysis of the Multistep Aggregation Pathway of Human Transthyretin. Proc. Natl. Acad. Sci. USA 2018, 115, E6201–E6208. https://doi.org/10.1073/pnas.1807024115.

  • 61.

    Rydzik, A.M.; Brem, J.R.; van Berkel, S.S.; et al. Monitoring Conformational Changes in the NDM-1 Metallo-β-Lactamase by 19F NMR Spectroscopy. Angew. Chem. Int. Ed. 2014, 53, 3129–3133. https://doi.org/10.1002/anie.201310866.

  • 62.

    Chrisman, I.M.; Nemetchek, M.D.; de Vera, I.M.S.; et al. Defining a Conformational Ensemble that Directs Activation of PPARγ. Nat. Commun. 2018, 9, 1794. https://doi.org/10.1038/s41467-018-04176-x.

  • 63.

    Ye, L.; Larda, S.T.; Frank Li, Y.F.; et al. A Comparison of Chemical Shift Sensitivity of Trifluoromethyl Tags: Optimizing Resolution in 19F NMR Studies of Proteins. J. Biomol. NMR 2015, 62, 97–103. https://doi.org/10.1007/s10858-015-9922-y.

  • 64.

    Huang, Y.; Wang, X.; Lv, G.; et al. Use of Paramagnetic 19F NMR to Monitor Domain Movement in a Glutamate Transporter Homolog. Nat. Chem. Biol. 2020, 16, 1006–1012. https://doi.org/10.1038/s41589-020-0561-6.

  • 65.

    Bondarenko, V.; Wells, M.M.; Chen, Q.; et al. 19F Paramagnetic Relaxation-Based NMR for Quaternary Structural Restraints of Ion Channels. ACS Chem. Biol. 2019, 14, 2160–2165. https://doi.org/10.1021/acschembio.9b00692.

  • 66.

    Huang, Y.; Reddy, K.D.; Bracken, C.; et al. Environmentally Ultrasensitive Fluorine Probe to Resolve Protein Conformational Ensembles by 19F NMR and Cryo-EM. J. Am. Chem. Soc. 2023, 145, 8583–8592. https://doi.org/10.1021/jacs.3c01003.

  • 67.

    Li, H.; Frieden, C. NMR Studies of 4-19F-Phenylalanine-Labeled Intestinal Fatty Acid Binding Protein:  Evidence for Conformational Heterogeneity in the Native State. Biochemistry 2005, 44, 2369–2377. https://doi.org/10.1021/bi047600l.

  • 68.

    Mani, R.; Cady, S.D.; Tang, M.; et al. Membrane-Dependent Oligomeric Structure and Pore Formation of a β-Hairpin Antimicrobial Peptide in Lipid Bilayers from Solid-State NMR. Proc. Natl. Acad. Sci. USA 2006, 103, 16242–16247. https://doi.org/10.1073/pnas.0605079103.

  • 69.

    Li, H.; Frieden, C. Observation of Sequential Steps in the Folding of Intestinal Fatty Acid Binding Protein Using a Slow Folding Mutant and 19F NMR. Proc. Natl. Acad. Sci. USA 2007, 104, 11993–11998. https://doi.org/10.1073/pnas.0705253104.

  • 70.

    Streit, J.O.; Chan, S.H.S.; Daya, S.; et al. Rational Design of 19F NMR Labelling Sites to Probe Protein Structure and Interactions. Biophysics 2025, 16, 4300. https://doi.org/10.1101/2024.12.11.627779.

  • 71.

    Luck, L.A.; Falke, J.J. Fluorine-19 NMR Studies of the D-Galactose Chemosensory Receptor. 1. Sugar Binding Yields a Global Structural Change. Biochemistry 1991, 30, 4248–4256. https://doi.org/10.1021/bi00231a021.

  • 72.

    Anderluh, G.; Razpotnik, A.; Podlesek, Z.; et al. Interaction of the Eukaryotic Pore-Forming Cytolysin Equinatoxin II with Model Membranes: 19F NMR Studies. J. Mol. Biol. 2005, 347, 27–39. https://doi.org/10.1016/j.jmb.2004.12.058.

  • 73.

    Patrick, J.; Pettersson, P.; Mäler, L. Lipid- and Substrate-Induced Conformational and Dynamic Changes in a Glycosyltransferase Involved in E. Coli LPS Synthesis Revealed by 19F and 31P NMR. Biochim. et Biophys. Acta BBA-Biomembr. 2023, 1865, 184209. https://doi.org/10.1016/j.bbamem.2023.184209.

  • 74.

    Evanics, F.; Bezsonova, I.; Marsh, J.; et al. Tryptophan Solvent Exposure in Folded and Unfolded States of an SH3 Domain by 19F and 1 H NMR. Biochemistry 2006, 45, 14120–14128. https://doi.org/10.1021/bi061389r.

  • 75.

    Bhuvaneshwari, R.A.; Shivamani, A.; Sengupta, I. Line Shape Analysis of 19F NMR-Monitored Chemical Denaturation of a Fold-Switching Protein RfaH Reveals Its Slow Folding Dynamics. J. Phys. Chem. B 2024, 128, 465–471. https://doi.org/10.1021/acs.jpcb.3c06550.

  • 76.

    Loscha, K.V.; Herlt, A.J.; Qi, R.; et al. Multiple-Site Labeling of Proteins with Unnatural Amino Acids. Angew. Chem. Int. Ed. 2012, 51, 2243–2246. https://doi.org/10.1002/anie.201108275.

  • 77.

    Wang, G.F.; Li, C.; Pielak, G.J. Probing the Micelle-Bound Aggregation-Prone State of α-Synuclein with 19F NMR Spectroscopy. ChemBioChem 2010, 11, 1993–1996. https://doi.org/10.1002/cbic.201000405.

  • 78.

    Wang, G.F.; Li, C.; Pielak, G.J. 19F NMR Studies of α-Synuclein-Membrane Interactions. Protein Sci. 2010, 19, 1686–1691. https://doi.org/10.1002/pro.449.

  • 79.

    Li, L.; Zhang, J.; Sun, W.; et al. Allosteric Conformational Changes of G Proteins upon Its Interaction with Membrane and GPCR. Chin. Chem. Lett. 2022, 33, 747–750. https://doi.org/10.1016/j.cclet.2021.07.042.

  • 80.

    Hanson, G.S.M.; Coxon, C.R. Fluorinated Tags to Study Protein Conformation and Interactions Using 19F NMR. ChemBioChem 2024, 25, e202400195. https://doi.org/10.1002/cbic.202400195.

  • 81.

    Chai, Z.; Wu, Q.; Cheng, K.; et al. Simultaneous Detection of Small Molecule Thiols with a Simple 19F NMR Platform. Chem. Sci. 2021, 12, 1095–1100. https://doi.org/10.1039/d0sc04664g.

  • 82.

    Chen, D.; Lin, Y.; Li, A.; et al. Bio-Orthogonal Metabolic Fluorine Labeling Enables Deep-Tissue Visualization of Tumor Cells in Vivo by 19F Magnetic Resonance Imaging. Anal. Chem. 2022, 94, 16614–16621. https://doi.org/10.1021/acs.analchem.2c02443.

  • 83.

    Sahani, P.A.; Patra, R.; Dixit, A. G Protein-Coupled Receptors (GPCRs) in Cancer Prognosis and Therapeutics: A Comprehensive Review. Int. J. Biol. Macromol. 2025, 328, 147665. https://doi.org/10.1016/j.ijbiomac.2025.147665.

  • 84.

    Chen, L.; Mao, C.; Jiang, Y. GPCR Signaling from Endosome: Mechanistic Insights and Therapeutic Potentials. Eur. J. Pharmacol. 2025, 1008, 178311. https://doi.org/10.1016/j.ejphar.2025.178311.

  • 85.

    Hauser, A.S.; Attwood, M.M.; Rask-Andersen, M.; et al. Trends in GPCR Drug Discovery: New Agents, Targets and Indications. Nat. Rev. Drug Discov. 2017, 16, 829–842. https://doi.org/10.1038/nrd.2017.178.

  • 86.

    Ye, L.; Van Eps, N.; Zimmer, M.; et al. Activation of the A2A Adenosine G-Protein-Coupled Receptor by Conformational Selection. Nature 2016, 533, 265–268. https://doi.org/10.1038/nature17668.

  • 87.

    Wang, H.; Hu, W.; Liu, D.; et al. Design and Preparation of the Class B G Protein-Coupled Receptors GLP-1R and GCGR for 19F-NMR Studies in Solution. FEBS J. 2021, 288, 4053–4063. https://doi.org/10.1111/febs.15686.

  • 88.

    Bautista, D.M.; Siemens, J.; Glazer, J.M.; et al. The Menthol Receptor TRPM8 Is the Principal Detector of Environmental Cold. Nature 2007, 448, 204–208. https://doi.org/10.1038/nature05910.

  • 89.

    Mebrat, M.D.; Luu, D.D.; Hilton, J.K.; et al. TRPM8 Protein Dynamics Correlates with Ligand Structure and Cellular Function. J. Am. Chem. Soc. 2025, 147, 18460–18474. https://doi.org/10.1021/jacs.4c09435.

  • 90.

    Daminato, A.; Loland, C.J.; Cabrita, E.J. Monitoring Conformational Changes in the Human Neurotransmitter Transporter Homologue LeuT with 19F-NMR Spectroscopy. J. Neurochem. 2025, 169, e16278. https://doi.org/10.1111/jnc.16278.

  • 91.

    Dong, W.; Wang, W.; Yang, Y.; et al. Transmembrane Domain Oligomerization and Intracellular Domain–Lipid Interaction Oppositely Modulates OX40 Receptor Activation Unveiled by 19F NMR. J. Am. Chem. Soc. 2026, 148, 23003–23014. https://doi.org/10.1021/jacs.6c04461.

  • 92.

    Shishmarev, D.; Fontenelle, C.; Kuprov, I.; et al. Transmembrane Exchange of Fluorosugars: Characterization of Red Cell GLUT1 Kinetics Using 19F NMR. Biophys. J. 2018, 115, 1906–1919. https://doi.org/10.1016/j.bpj.2018.09.030.

  • 93.

    Luchinat, E.; Cremonini, M.; Banci, L. Radio Signals from Live Cells: The Coming of Age of in-Cell Solution NMR. Chem. Rev. 2022, 122, 9267–9306. https://doi.org/10.1021/acs.chemrev.1c00790.

  • 94.

    Zhu, W.; Guseman, A.J.; Bhinderwala, F.; et al. Visualizing Proteins in Mammalian Cells by 19F NMR Spectroscopy. Angew. Chem. Int. Ed. 2022, 61, e202201097. https://doi.org/10.1002/anie.202201097.

  • 95.

    Seal, M.; Zhu, W.; Dalaloyan, A.; et al. GdIII-19F Distance Measurements for Proteins in Cells by Electron-Nuclear Double Resonance. Angew. Chem. Int. Ed. 2023, 62, e202218780. https://doi.org/10.1002/anie.202218780.

  • 96.

    Ikari, M.; Yagi, H.; Kasai, T.; et al. Direct Observation of Membrane-Associated H-Ras in the Native Cellular Environment by in-Cell 19F-NMR Spectroscopy. JACS Au 2023, 3, 1658–1669. https://doi.org/10.1021/jacsau.3c00108.

  • 97.

    Takechi-Haraya, Y.; Aki, K.; Tohyama, Y.; et al. Glycosaminoglycan Binding and Non-Endocytic Membrane Translocation of Cell-Permeable Octaarginine Monitored by Real-Time in-Cell NMR Spectroscopy. Pharmaceuticals 2017, 10, 42. https://doi.org/10.3390/ph10020042.

  • 98.

    Pan, B.; Liu, D.; Yang, L.; et al. GPCR Large-Amplitude Dynamics by 19F-NMR of Aprepitant Bound to the Neurokinin 1 Receptor. Proc. Natl. Acad. Sci. USA 2022, 119, e2122682119. https://doi.org/10.1073/pnas.2122682119.

  • 99.

    Khananshvili, D. The Archaeal Na+/Ca2+ Exchanger (NCX_Mj) as a Model of Ion Transport for the Superfamily of Ca2+/CA Antiporters. Front. Chem. 2021, 9, 722336. https://doi.org/10.3389/fchem.2021.722336.

  • 100.

    Bai, J.; Wang, J.; Ravula, T.; et al. Expression, Purification, and Functional Reconstitution of 19F-Labeled Cytochrome b5 in Peptide Nanodiscs for NMR Studies. Biochim. et Biophys. Acta BBA-Biomembr. 2020, 1862, 183194. https://doi.org/10.1016/j.bbamem.2020.183194.

  • 101.

    de la Torre, B.G.; Albericio, F. The Pharmaceutical Industry in 2018. an Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules 2019, 24, 809. https://doi.org/10.3390/molecules24040809.

  • 102.

    Fernández, C.S.; Jahnke, W. New Approaches for NMR Screening in Drug Discovery. Drug Discov. Today Technol. 2004, 1, 277–283. https://doi.org/10.1016/j.ddtec.2004.10.003.

  • 103.

    Mikaeili, H.; Habib, A.M.; Yeung, C.W.L.; et al. Molecular Basis of FAAH-out-Associated Human Pain Insensitivity. Brain 2023, 146, 3851–3865. https://doi.org/10.1093/brain/awad098.

  • 104.

    Kathuria, S.; Gaetani, S.; Fegley, D.; et al. Modulation of Anxiety through Blockade of Anandamide Hydrolysis. Nat. Med. 2003, 9, 76–81. https://doi.org/10.1038/nm803.

  • 105.

    Lambruschini, C.; Veronesi, M.; Romeo, E.; et al. Development of Fragment-Based N-FABS NMR Screening Applied to the Membrane Enzyme FAAH. ChemBioChem 2013, 14, 1611–1619. https://doi.org/10.1002/cbic.201300347.

  • 106.

    Shinya, S.; Katahira, R.; Furuita, K.; et al. 19F Chemical Library and 19F-NMR for a Weakly Bound Complex Structure. RSC Med. Chem. 2022, 13, 1100–1111. https://doi.org/10.1039/d2md00170e.

  • 107.

    Sušac, L.; Eddy, M.T.; Didenko, T.; et al. A2A Adenosine Receptor Functional States Characterized by 19F-NMR. Proc. Natl. Acad. Sci. USA 2018, 115, 12733–12738. https://doi.org/10.1073/pnas.1813649115.

  • 108.

    Jarmoskaite, I.; AlSadhan, I.; Vaidyanathan, P.P.; et al. How to Measure and Evaluate Binding Affinities. eLife 2020, 9, e57264. https://doi.org/10.7554/elife.57264.

  • 109.

    Dalvit, C.; Vulpetti, A. Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects. J. Med. Chem. 2018, 62, 2218–2244. https://doi.org/10.1021/acs.jmedchem.8b01210.

  • 110.

    Zhu, W.; Bhinderwala, F.; Rambo, S.; et al. Quantifying Protein-Drug Lifetimes in Human Cells by 19F NMR Spectroscopy. J. Biomol. NMR 2025, 79, 209–219. https://doi.org/10.1007/s10858-025-00466-x.

  • 111.

    Slamon, D.J.; Clark, G.M.; Wong, S.G.; et al. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/Neu Oncogene. Science 1987, 235, 177–182. https://doi.org/10.1126/science.3798106.

  • 112.

    Zhou, X.; Liang, Y.; Zhang, X.; et al. Distinct Effects of the Extracellular Domain and Antibody Binding on HER2 Transmembrane and Juxtamembrane Regions Unveiled by NMR and EPR. J. Am. Chem. Soc. 2026, 148, 10366–10377. https://doi.org/10.1021/jacs.5c11966.

  • 113.

    Kim, T.H.; Chung, K.Y.; Manglik, A.; et al. The Role of Ligands on the Equilibria between Functional States of a G Protein-Coupled Receptor. J. Am. Chem. Soc. 2013, 135, 9465–9474. https://doi.org/10.1021/ja404305k.

  • 114.

    Orton, H.W.; Qianzhu, H.; Abdelkader, E.H.; et al. Through-Space Scalar 19F–19F Couplings between Fluorinated Noncanonical Amino Acids for the Detection of Specific Contacts in Proteins. J. Am. Chem. Soc. 2021, 143, 19587–19598. https://doi.org/10.1021/jacs.1c10104.

  • 115.

    Movellan, K.T.; Banks, D.; Reiter, C.; et al. Pushing Sensitivity and Specificity Limits in Native Structural Biology: 19F Multinuclear Dynamic Nuclear Polarization with Magic Angle Spinning. J. Am. Chem. Soc. 2025, 147, 29970–29976. https://doi.org/10.1021/jacs.5c06739.

  • 116.

    Vulpetti, A.; Lingel, A.; Dalvit, C.; et al. Efficient Screening of Target-Specific Selected Compounds in Mixtures by 19F NMR Binding Assay with Predicted 19F NMR Chemical Shifts. ChemMedChem 2022, 17, e202200163. https://doi.org/10.1002/cmdc.202200163.

  • 117.

    Dietschreit, J.C.B.; Wagner, A.; Le, T.A.; et al. Predicting 19F NMR Chemical Shifts: A Combined Computational and Experimental Study of a Trypanosomal Oxidoreductase–Inhibitor Complex. Angew. Chem. Int. Ed. 2020, 59, 12669–12673. https://doi.org/10.1002/anie.202000539.

Share this article:
How to Cite
Zhou, Z.; Dong, W.; Cao, C. 19F NMR as a Powerful Tool for Revealing Disease- and Metabolism-Related Membrane Protein Dynamics. Health and Metabolism 2026, 3 (4), 5. https://doi.org/10.53941/hm.2026.100027.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2026 by the authors.
Article Metrics
37
Article Views
0
Citations